Lowest Price Guaranteed
Pages
187
Last Updated
August 2026
View Count
5488
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
2.5. Robust Quality Control
3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Major Currencies Affecting the Market
4.2.2.2. Factors Affecting Currency Fluctuations
4.2.2.3. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Currency Exchange Rate
4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.8.3. Trade Policies
4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
4.2.8.5. Impact of Trade Barriers on the Market
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. Stock Market Performance
4.2.11.7. Cross Border Dynamics
4.3. Conclusion
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Peptides
6.2.1. Structural Analysis of Peptides
6.2.2. Classification of Peptides
6.2.3. Peptide Synthesis
6.2.4. Emerging Technologies for Peptide Synthesis
6.2.5. Peptide Modification
6.2.5.1. N-terminal Modifications
6.2.5.2. Internal Modifications
6.2.5.3. C-terminal Modifications
6.2.5.4. Other Modifications
6.2.6. Peptide Purification
6.2.7. Peptide Purity Guidelines
6.3. Overview of Contract Manufacturing
6.3.1. Need for Outsourcing in the Peptide Manufacturing Industry
6.3.2. General Considerations for Selecting a CMO Partner
6.3.3. Advantages of Outsourcing Manufacturing Operations
6.3.4. Risks and Challenges Associated with Outsourcing of Peptide API Manufacturing
6.4. Future Perspectives
7. MARKET LANDSCAPE
7.1. Chapter Overview
7.2. Europe Peptide Synthesis Market: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Year of Experience of Peptide API Contract Manufacturers
7.2.3. Analysis by Company Size
7.2.4. Analysis by Location of Headquarters
7.2.5. Analysis by Type of Product Manufactured
7.2.6. Analysis by Type of API Manufactured
7.2.7. Analysis by Scale of Operation
7.2.8. Analysis by Type of Service Offered
7.2.9. Analysis by Type of Peptide Synthesis Method Used
7.2.10. Analysis by Type of Peptide Modification Offered
7.2.11. Analysis by Type of Purification Technology Used
7.2.12. Analysis by Regulatory Certifications and Accreditations
7.2.13. Analysis by Geographical Presence
7.2.14. Analysis by Location of Peptide API Manufacturing Facilities
7.3. List of Custom Peptide Manufacturers
8. COMPANY PROFILES
8.1. Chapter Overview
8.2. Almac Sciences*
8.2.1. Company Overview
8.2.2. Peptide Synthesis Service Portfolio
8.2.3. Recent Developments and Future Outlook
* Similar details are presented for other companies mentioned below (based on information in the public domain)
8.3. Bachem
8.4. BCN Peptides
8.5. Biosynth
8.6. CordenPharma
8.7. PolyPeptide
9. RECENT DEVELOPMENTS
9.1. Chapter Overview
9.2. Partnerships and Collaborations
9.2.1. Partnership Models
9.2.2. List of Partnerships and Collaborations
9.2.3. Analysis by Year of Partnership
9.2.4. Analysis by Type of Partnership
9.2.5. Analysis by Year and Type of Partnership
9.2.6. Analysis by Company Size and Type of Partnership
9.2.7. Analysis by Scale of Operation
9.2.8. Analysis by Scale of Operation and Type of Partnership
9.2.9. Analysis by Green Chemistry Integration
9.2.10. Most Active Players: Analysis by Number of Partnerships
9.3. Recent Expansions
9.3.1. Expansion Models
9.3.2. List of Recent Expansions
9.3.3. Analysis by Year of Expansion
9.3.4. Analysis by Type of Expansion
9.3.5. Analysis by Year and Type of Expansion
9.3.6. Analysis by Location of Expanded Facility (Country)
9.3.7. Recent Expansions: Analysis by Location of Expanded Facility and Type of Expansion
9.3.8. Most Active Players: Analysis by Number of Expansions
9.3.9. Recent Expansions: Analysis by Geography (Country)
9.4. Emerging Peptide Synthesis Technologies
9.4.1. Chemo-Enzymatic Peptide Synthesis Technology
9.4.2. Continuous Flow Technology
9.4.3. Green Chemistry
10. CLINICAL TRIAL ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Europe Peptide Synthesis Market: Clinical Trials Analysis
10.3.1. Analysis by Trial Registration Year
10.3.2. Analysis by Number of Patients Enrolled by Trial Registration Year
10.3.3. Analysis by Trial Phase
10.3.4. Analysis of Trials by Trial Registration Year and Trial Phase
10.3.5. Analysis by Number of Patients Enrolled by Trial Phase
10.3.6. Analysis by Trial Status
10.3.7. Analysis by Trial Registration Year and Trial Status
10.3.8. Analysis by Therapeutic Area
10.3.9. Analysis by Patient Gender
10.3.10. Analysis by Type of Sponsor / Collaborator
10.3.11. Analysis by Study Design
10.3.11.1. Analysis by Type of Allocation
10.3.11.2. Analysis by Type of Masking
10.3.11.3. Analysis by Type of Intervention
10.3.11.4. Analysis by Trial Purpose
10.3.12. Leading Industry Players: Analysis by Number of Clinical Trials
11. DEMAND ANALYSIS
11.1. Chapter Overview
11.2. Assumptions and Methodology
11.3. Europe Peptide Synthesis Market: Annual Demand
11.3.1. Europe Peptide Synthesis Market: Annual Clinical Demand
11.3.1.1. Clinical Demand for Peptide Synthesis: Analysis by Phase of Development
11.3.2. Europe Peptide Synthesis Market: Annual Commercial Demand
11.3.2.1. Commercial Demand for Peptide Synthesis: Analysis by Mechanism of Action
11.3.3. Europe Peptide Synthesis Market: Analysis by Type of Peptide Synthesis Method
12. CAPACITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Europe Peptide Synthesis Market: Installed Capacity
12.3.1. Analysis by Company Size
12.3.2. Analysis by Scale of Operation
12.3.3. Analysis by Company Size and Location of Manufacturing Facility
12.3.4. Analysis by Chemical Synthesis Method Used
12.4. Concluding Remarks
13. MAKE VERSUS BUY DECISION MAKING FRAMEWORK
13.1. Chapter Overview
13.2. Assumptions and Parameter Definitions
13.3. Make versus Buy Decision Making Framework
13.3.1. Scenario 1
13.3.2. Scenario 2
13.3.3. Scenario 3
13.3.4. Scenario 4
13.4. Concluding Remarks
14. EUROPE PEPTIDE SYNTHESIS MARKET
14.1. Chapter Overview
14.2. Assumptions and Methodology
14.3. Roots Analysis Perspective on Market Growth
14.4. Europe Peptide Synthesis Market: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
14.4.1. Scenario Analysis
14.4.1.1. Conservative Scenario
14.4.1.2. Optimistic Scenario
14.5. Key Market Segmentation
15. EUROPE PEPTIDE SYNTHESIS MARKET, BY TYPE OF API
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Europe Peptide Synthesis Market: Distribution by Type of API
15.3.1. Europe Peptide Synthesis Market for Generic APIs: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
15.3.2. Europe Peptide Synthesis Market for New Chemical Entities: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
15.4. Data Triangulation and Validation
16. EUROPE PEPTIDE SYNTHESIS MARKET, BY TYPE OF PEPTIDE SYNTHESIS METHOD
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Europe Peptide Synthesis Market: Distribution by Type of Peptide Synthesis Method
16.3.1. Europe Peptide Synthesis Market for Chemical Synthesis: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
16.3.2. Europe Peptide Synthesis Market for Non-Chemical Synthesis: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
16.4. Data Triangulation and Validation
17. EUROPE PEPTIDE SYNTHESIS MARKET, BY TYPE OF CHEMICAL SYNTHESIS METHOD
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Europe Peptide Synthesis Market: Distribution by Type of Chemical Synthesis Method
17.3.1. Europe Peptide Synthesis Market for Solid Phase Synthesis: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
17.3.2. Europe Peptide Synthesis Market for Liquid Phase Synthesis: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
17.3.3. Europe Peptide Synthesis Market for Hybrid Phase Synthesis: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
17.4. Data Triangulation and Validation
18. EUROPE PEPTIDE SYNTHESIS MARKET, BY SCALE OF OPERATION
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Europe Peptide Synthesis Market: Distribution by Scale of Operation
18.3.1. Europe Peptide Synthesis Market for Preclinical / Clinical Scale: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
18.3.2. Europe Peptide Synthesis Market for Commercial Scale: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
18.4. Data Triangulation and Validation
19. EUROPE PEPTIDE SYNTHESIS MARKET, BY COMPANY SIZE
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Europe Peptide Synthesis Market: Distribution by Company Size
19.3.1. Europe Peptide Synthesis Market for Small Companies: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
19.3.2. Europe Peptide Synthesis Market for Mid-sized Companies: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
19.3.3. Europe Peptide Synthesis Market for Large and Very Large Companies: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
19.4. Data Triangulation and Validation
20. EUROPE PEPTIDE SYNTHESIS MARKET, BY COUNTRY
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Europe Peptide Synthesis Market: Distribution by Country
20.3.1. Europe Peptide Synthesis Market in Belgium: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
20.3.2. Europe Peptide Synthesis Market in Switzerland: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
20.3.3. Europe Peptide Synthesis Market in the UK: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
20.3.4. Europe Peptide Synthesis Market in Germany: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
20.3.5. Europe Peptide Synthesis Market in Ireland: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
20.3.6. Europe Peptide Synthesis Market in Netherlands: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
20.3.7. Europe Peptide Synthesis Market in Italy: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
20.3.8. Europe Peptide Synthesis Market in France: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
20.3.9. Europe Peptide Synthesis Market in Sweden: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
20.3.10. Europe Peptide Synthesis Market in Rest of European Countries: Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
20.4. Data Triangulation and Validation
21. CONCLUSION
22. EXECUTIVE INSIGHTS
22.1. Chapter Overview
22.2. Company A
22.2.1. Company Snapshot
22.2.2. Interview Transcript: Chief Scientific Officer, Co-Founder
22.3. Company B
22.3.1. Company Snapshot
22.3.2. Interview Transcript: Chief Financial Officer
22.4. Company C
22.4.1. Company Snapshot
22.4.2. Interview Transcript: Chief Business Officer
22.5. Company D
22.5.1. Company Snapshot
22.5.2. Interview Transcript: Founder and Owner
22.6. Company E
22.6.1. Company Snapshot
22.6.2. Interview Transcript: Vice President
22.7. Company F
22.7.1. Company Snapshot
22.7.2. Interview Transcript: Senior Director of Scientific Affairs and Technical Marketing
22.8. Company G
22.8.1. Company Snapshot
22.8.2. Interview Transcript: Senior Manager, Peptide Business Project Leader
22.9. Company H
22.9.1. Company Snapshot
22.9.2. Interview Transcript: Chief Executive Officer and President
22.10. Company I
22.10.1. Company Snapshot
22.10.2. Interview Transcript: Chief Executive Officer and President
22.11. Company J
22.11.1. Company Snapshot
22.11.2. Interview Transcript: Chief Executive Officer
22.12. Company K
22.12.1. Company Snapshot
22.12.2. Interview Transcript: Chief Executive Officer
22.13. Company L
22.13.1. Company Snapshot
22.13.2. Interview Transcript: Chief Scientific Officer
22.14. Company M
22.14.1. Company Snapshot
22.14.2. Interview Transcript: Chief Scientific Officer
22.15. Company N
22.15.1. Company Snapshot
22.15.2. Interview Transcript: Chief Scientific Officer
22.16. Company O
22.16.1. Company Snapshot
22.16.2. Interview Transcript: Chief Solutions Officer
22.17. Company P
22.17.1. Company Snapshot
22.17.2. Interview Transcript: Executive Director and Head of Biocatalysis
22.18. Company Q
22.18.1. Company Snapshot
22.18.2. Interview Transcript: Vice President of Research and Development
23. APPENDIX I: TABULATED DATA
24. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS